Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Calabresi

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
Cardiovascular Research|June 9, 2014
HDL and cholesterol handling in the brainCecilia Vitali, Cheryl L Wellington, Laura Calabresi
Atherosclerosis|December 23, 2011
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular diseaseLaura Calabresi, Sara Simonelli, Monica Gomaraschi, et al.
Pharmacology & Therapeutics|September 9, 2006
Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injuryLaura Calabresi, Monica Gomaraschi, Giuseppe Rossoni, et al.
Annals of Medicine|August 9, 2017
Nutraceutical approaches to metabolic syndromeCesare R Sirtori, Chiara Pavanello, Laura Calabresi, et al.
Current Atherosclerosis Reports|March 3, 2006
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseasesLaura Calabresi, Cesare R Sirtori, Rodolfo Paoletti, et al.
Biochemical and Biophysical Research Communications|December 10, 2002
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol effluxElda Favari, Franco Bernini, Patrizia Tarugi, et al.
Biochimica Et Biophysica Acta|July 29, 2014
HDL and atherosclerosis: Insights from inherited HDL disordersLaura Calabresi, Monica Gomaraschi, Sara Simonelli, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 14, 2016
[Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy]Fabio Lucca, Alice Ossoli, Giuliano Boscutti, et al.
Journal of Atherosclerosis and Thrombosis|November 27, 2015
Role of LCAT in AtherosclerosisAlice Ossoli, Sara Simonelli, Cecilia Vitali, et al.
Current Medicinal Chemistry|March 17, 2018
Dysfunctional HDL as a Therapeutic Target for Atherosclerosis PreventionAlice Ossoli, Chiara Pavanello, Eleonora Giorgio, et al.
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Cardiovascular Research|June 9, 2014
HDL and cholesterol handling in the brainCecilia Vitali, Cheryl L Wellington, Laura Calabresi
Atherosclerosis|December 23, 2011
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular diseaseLaura Calabresi, Sara Simonelli, Monica Gomaraschi, et al.
Pharmacology & Therapeutics|September 9, 2006
Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injuryLaura Calabresi, Monica Gomaraschi, Giuseppe Rossoni, et al.
Annals of Medicine|August 9, 2017
Nutraceutical approaches to metabolic syndromeCesare R Sirtori, Chiara Pavanello, Laura Calabresi, et al.
Current Atherosclerosis Reports|March 3, 2006
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseasesLaura Calabresi, Cesare R Sirtori, Rodolfo Paoletti, et al.
Biochemical and Biophysical Research Communications|December 10, 2002
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol effluxElda Favari, Franco Bernini, Patrizia Tarugi, et al.
Biochimica Et Biophysica Acta|July 29, 2014
HDL and atherosclerosis: Insights from inherited HDL disordersLaura Calabresi, Monica Gomaraschi, Sara Simonelli, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 14, 2016
[Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy]Fabio Lucca, Alice Ossoli, Giuliano Boscutti, et al.
Journal of Atherosclerosis and Thrombosis|November 27, 2015
Role of LCAT in AtherosclerosisAlice Ossoli, Sara Simonelli, Cecilia Vitali, et al.
Current Medicinal Chemistry|March 17, 2018
Dysfunctional HDL as a Therapeutic Target for Atherosclerosis PreventionAlice Ossoli, Chiara Pavanello, Eleonora Giorgio, et al.
Pageof 17